ViroPharma (VPHM) Up 25% on Shire Acquisition (SHPG)
Biotech Stocks Perk Up on Shire/ViroPharma Merger Sweet Spot of The Market- Mid-Caps With Sales Growth One of the core Rayno Biopharmaceutical stock picks is up 25% to $49.37 in a $4.2B deal. ViroPharma, Inc. is a rare disease drug Company whose commercial product CIN-RYZE is a leading brand...
Stealth Sell-Off in Biotech Stocks: AEGR, INCY, MDVN, REGN, PCYC Update 2 11/8
Strong Jobs Report Boosts Market--Treasuries Sell -Off with 10 Year up to 2.74% Volatile Week Finds Buyers-Technical Levels Hold 11/8/13 9:45 a Biotechnology stocks rebounded today with the IBB up 3% to $203.86. The sector hit a major downdraft yesterday but we are still well above Q3 lows...
Rayno Biopharmaceutical Update: CBST,IMGN,REGN,VPHM and Large Caps Rule
Biotech Remains Strong But Momentum Is Easing Biotechnology stocks were positive today but major ETFs mixed with the FBT ($63.82) off 1.45%. Profit taking has hit some high fliers (AEGR,INCY) and many of our portfolio stocks are off their recent highs. Small and mid-caps are being sold off...
Rayno Biopharmaceutical Portfolio Nov. 1, 2013 YTD Performance…Update 1
Updated 2/11/15 see chart below Rayno 2013 Picks Outperform Biotechnology Indices and Funds Biopharmaceutical stocks hit all time highs in 2013 with major ETFs up as follows YTD: FBT ($65) up 41%, IBB ($206) up 50%, and XBI ((%120) up 36%. The Five Star Fidelity Select Biotechnology Fund...
Rayno Life Science Scoreboard- October 2013- Amidst Sell-Off
Equities: The Only Game in Town With Rates Under 3%? October, normally a month to be cautious on the market, proved that trends can be misleading even in the midst of turbulent times in Washington. DOW Up 2.5%, S&P Up 3.5%, NASDAQ Up 2.5%. Healthcare stocks followed suit with the broadly...